Shaun Mc Kinnie advances natural product biosynthesis and enzyme‑enabled synthesis. A co‑inventor on two issued patents (kainic acid bioproduction; apelin peptides), he leads an R35‑funded program on microbial halogenating enzymes. Using genomics, fractionation, and MS/NMR, he delivers scalable biocatalysis and toxin‑monitoring tools.